ArticleJACC. Case reports2026

ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a.

Joseph Burns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.